Crouzonodermoskeletal syndrome.
D000052:Acanthosis Nigricans / Q000473:pathology*; D000848:Anodontia / Q000209:etiology*; D002754:Choanal Atresia / Q000209:etiology / Q000601:surgery; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics*; D003394:Craniofacial Dysostosis / Q000150:complications / Q000235:genetics / Q000473:pathology* / Q000601:surgery; D019066:Facies; D005260:Female; D005385:Fingers / Q000002:abnormalities; D006801:Humans; D006849:Hydrocephalus / Q000209:etiology / Q000601:surgery; D007231:Infant, Newborn; D017354:Point Mutation; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3; D017468:Receptors, Fibroblast Growth Factor / Q000235:genetics*; D063173:Retrognathia; D013131:Spine / Q000002:abnormalities; D013577:Syndrome
D017468:Receptors, Fibroblast Growth Factor; C496365:FGFR3 protein, human; D011505:Protein-Tyrosine Kinases; D051498:Receptor, Fibroblast Growth Factor, Type 3